Dapagliflozin and measures of cardiovascular autonomic function in patients with type 2 diabetes

被引：0
|
作者：
Ang, L. [1 ]
Kidwell, K. [2 ]
Dillon, B. [3 ]
Reiss, J. [1 ]
Leone, V. [4 ]
Mizokami-Stout, K. [1 ]
Busui, R. [1 ]
机构：
[1] Univ Michigan, Metab Endocrinol & Diabet Div, Internal Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Med, Ann Arbor, MI USA
[4] Univ Michigan, Metab Endocrinol & Diabet Div, Ann Arbor, MI 48109 USA
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
844
引用
收藏
页码：S406 / S406
页数：1
相关论文
共 50 条
  • [1] Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients with Type 2 Diabetes
    Ang, Lynn
    Kidwell, Kelley M.
    Reiss, Jacob
    Dillon, Brendan R.
    Mizokami-Stout, Kara R.
    Leone, Virginia A.
    Pop-Busui, Rodica
    [J]. DIABETES, 2020, 69
  • [2] Dapagliflozin and measures of cardiovascular autonomic function in patients with type 2 diabetes (T2D)
    Ang, Lynn
    Kidwell, Kelley M.
    Dillon, Brendan
    Reiss, Jacob
    Fang, Fang
    Leone, Virginia
    Mizokami-Stout, Kara
    Pop-Busui, Rodica
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (08)
  • [3] Dapagliflozin improves cardiac autonomic function measures in type 2 diabetic patients with cardiac autonomic neuropathy
    Balcioglu, Akif Serhat
    Celik, Enes
    Sahin, Murat
    Gocer, Kemal
    Aksu, Ekrem
    Aykan, Ahmet Cagri
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2022, 26 : S72 - S73
  • [4] Dapagliflozin Improves Cardiac Autonomic Function Measures in Type 2 Diabetic Patients with Cardiac Autonomic Neuropathy
    Balcioglu, Akif Serhat
    Celik, Enes
    Sahin, Murat
    Gocer, Kemal
    Aksu, Ekrem
    Aykan, Ahmet Cagri
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2022, 26 (11): : 832 - 840
  • [5] Dapagliflozin and cardiovascular outcomes in patients with Type 2 diabetes
    Al-Bazz, Dalai Y.
    Wilding, John P. H.
    [J]. FUTURE CARDIOLOGY, 2020, 16 (02) : 77 - 88
  • [6] Cardiovascular Outcomes with Dapagliflozin for Patients with Type 2 Diabetes
    Pavlicek, Vojtech
    [J]. DIABETOLOGE, 2019, 15 (03): : 262 - 264
  • [7] Cardiovascular autonomic neuropathy in patients with type 2 diabetes
    Liu, Yuan
    Liu, Sui-xin
    Zheng, Fan
    Cai, Ying
    Xie, Kang-ling
    Zhang, Wen-liang
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (04) : 615 - 621
  • [8] Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
    Wiviott, S. D.
    Raz, I.
    Bonaca, M. P.
    Mosenzon, O.
    Kato, E. T.
    Cahn, A.
    Silverman, M. G.
    Zelniker, T. A.
    Kuder, J. F.
    Murphy, S. A.
    Bhatt, D. L.
    Leiter, L. A.
    McGuire, D. K.
    Wilding, J. P. H.
    Ruff, C. T.
    Gause-Nilsson, I. A. M.
    Fredriksson, M.
    Johansson, P. A.
    Langkilde, A-M.
    Sabatine, M. S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (04): : 347 - 357
  • [9] The effect of dapagliflozin on renal function in patients with type 2 diabetes
    Donald Elliott Kohan
    Paola Fioretto
    Kristina Johnsson
    Shamik Parikh
    Agata Ptaszynska
    Lisa Ying
    [J]. Journal of Nephrology, 2016, 29 : 391 - 400
  • [10] The effect of dapagliflozin on renal function in patients with type 2 diabetes
    Kohan, Donald Elliott
    Fioretto, Paola
    Johnsson, Kristina
    Parikh, Shamik
    Ptaszynska, Agata
    Ying, Lisa
    [J]. JOURNAL OF NEPHROLOGY, 2016, 29 (03) : 391 - 400
12345